Project: Efficacy and cost-effectiveness of new anticoagulants in patients with atrial fibrillation
Short description and summary (English)
Atrial fibrillation is a rhythm disturbance in the heart. Due to irregular electrical impulses, the atria and ventricles do
not contract simultaneously as they normally do. This results in uneven blood flow and increased risk of blood clot formation.
These clots may follow the blood flow and cause stroke or systemic embolism in other parts of the body. To prevent thromboembolic
events, it is recommended that patients with atrial fibrillation and intermediate to high risk of stroke receive blood-thinning
treatment. In this project we will investigate the efficacy and cost-effectiveness of new anticoagulants compared to warfarin
for stroke prevention in patients with atrial fibrillation.